Cargando…
Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis
BACKGROUND: Ferroptosis is a newly recognized type of cell death, which is different from traditional necrosis, apoptosis or autophagic cell death. However, the position of ferroptosis in lipopolysaccharide (LPS)-induced acute lung injury (ALI) has not been explored intensively so far. In this study...
Autores principales: | Liu, Pengfei, Feng, Yetong, Li, Hanwei, Chen, Xin, Wang, Guangsuo, Xu, Shiyuan, Li, Yalan, Zhao, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045739/ https://www.ncbi.nlm.nih.gov/pubmed/32161620 http://dx.doi.org/10.1186/s11658-020-00205-0 |
Ejemplares similares
-
Ferrostatin-1 alleviates cytotoxicity of cobalt nanoparticles by inhibiting ferroptosis
por: Zhang, Weinan, et al.
Publicado: (2022) -
Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction
por: Xiao, Zheng, et al.
Publicado: (2021) -
Insight into the mechanism of ferroptosis inhibition by ferrostatin-1
por: Miotto, Giovanni, et al.
Publicado: (2019) -
Ferrostatin-1 alleviates oxalate-induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis
por: Xie, Jinna, et al.
Publicado: (2022) -
Ferroptosis contributes to isoflurane-induced neurotoxicity and learning and memory impairment
por: Liu, Pengfei, et al.
Publicado: (2021)